C286, an orally available retinoic acid receptor β agonist drug, regulates multiple pathways to achieve spinal cord injury repair - Goncalves, Maria B.; Wu, Yue; Clarke, Earl; Grist, John; Moehlin, Julien; Mendoza-Parra, Marco Antonio; Hobbs, Carl; Kalindjian, Barret; Fok, Henry; Mander, Adrian P.; Hassanin, Hana; Bendel, Daryl; et al. (Frontiers in Molecular Neuroscience, 2024)